A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death

Journal of Medical Microbiology

Volumn 60, Issue 7, 2011, Pages 920-926

  Edler, Carolin ^a   Wulff, Birgit ^a   Schröder, Ann Sophie ^a   Wilkemeyer, Ina ^b   Polywka, Susanne ^a   Meyer, Thomas ^a   Kalus, Ulrich ^b   Pruss, Axel ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; AUTOPSY; BLOOD SAMPLING; CONTROLLED STUDY; DEATH; DONOR; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEROLOGIC TESTS; TIME FACTORS;

EID: 79959520553     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.027763-0     Document Type: Article

References (15)

1. Challine, D., Roudot-Thoraval, F., Sabatier, P., Dubernet, F., Larderie, P., Rigot, P. & Pawlotsky, J. M. (2006). Serological viral testing of cadaveric cornea donors. Transplantation 82, 788-793.
2. Essex, M., Allan, J., Kanki, P., McLane, M. F., Malone, G., Kitchen, L. & Lee, T. H. (1985). Antigens of human T-lymphotropic virus type III/ lymphadenopathy-associated virus. Ann Intern Med 103, 700-703.
3. European Union (2004). Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union 04.07.2004 102, 48-58.
4. European Union (2006). Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Official Journal of the European Union 02.09.2006 38, 40-52.
5. Federal Ministry of Justice (2010). Report of the German Government about the Supply with Tissues and Tissue Preparations in Germany (Article 7a GewG). 10.08.2010. http://www.bmg.bund.de/ fileadmin/redaktion/pdf_misc/Bericht-BReg-Gewebe.pdf
6. Federal Ministry of Justice (2010). Report of the German Government about the Supply with Tissues and Tissue Preparations in Germany (Article 7a GewG). 10.08.2010. http://www.bmg.bund.de/ fileadmin/redaktion/pdf_misc/Bericht-BReg-Gewebe.pdf
7. Heim, A., Wagner, D., Rothämel, T., Hartmann, U., Flik, J. & Verhagen, W. (1999). Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation. J Med Virol 58, 291-295.
8. Kitchen, A. D. & Newham, J. A. (2011). Qualification of serological infectious disease assays for the screening of tissue samples from deceased donors. Cell Tissue Bank 12, 117-124.
9. Laycock, K. A., Essary, L. R., Delaney, S., Kuhns, M. C. & Pepose, J. S. (1997). A critical evaluation of hepatitis C testing of cadaveric corneal donors. Cornea 16, 146-150.
10. Pepose, J. S., MacRae, S., Quinn, T. C. & Ward, J. W. (1987). Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus. Am J Ophthalmol 103, 798-801.
11. Pepose, J. S., Buerger, D. G., Paul, D. A., Quinn, T. C., Darragh, T. M. & Donegan, E. (1992). New developments in serologic screening of corneal donors for HIV-1 and hepatitis B virus infections. Ophthalmology 99, 879-888.
12. Pruss, A., Caspari, G., Krüger, D. H., Blümel, J., Nübling, C. M., Gürtler, L. & Gerlich, W. H. (2010). Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis 12, 375-386.
13. Püschel, K., Mohsenian, F., Laufs, R., Polywka, S. & Ermer, M. (1991). Postmortem viability of the human immunodeficiency virus. Int J Legal Med 104, 109-110.
14. Yao, F., Seed, C., Farrugia, A., Morgan, D., Cordner, S., Wood, D. & Zheng, M. H. (2007). The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J Transplant 7, 2723-2726.
15. Zou, S., Dodd, R. Y., Stramer, S. L. & Strong, D. M. for the Tissue Safety Study Group (2004). Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 351, 751-759.